Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5711943 | 0.93 | ADRB2 (0.35) | ADRB2ADRB1ADRB3TSHRLMNA | |
| SCHEMBL5711968 | 0.93 | ADRB2 (0.35) | ADRB2ADRB1ADRB3TSHRLMNA | |
| SCHEMBL49555 | 0.83 | ADRB2 (0.45) | ADRB2ADRB1ADRB3TSHRLMNA | |
| SCHEMBL29053698 | 0.80 | ADRB2 (0.43) | ADRB2ADRB1ADRB3TSHRLMNA | |
| SCHEMBL11408202 | 0.79 | ADRB2 (0.35) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL5711958 | 0.78 | — | — | |
| SCHEMBL5711942 | 0.78 | — | — | |
| SCHEMBL5711947 | 0.78 | — | — | |
| SCHEMBL17644807 | 0.78 | ADRB2 (0.41) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL17644809 | 0.78 | ADRB2 (0.41) | ADRB2ADRB1ADRB3TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014041513-A1 | A MATERIAL USED FOR PHOSPHOPEPTIDE ENRICHMENT AND A PRODUCTION METHOD THEREOF | SALIH BEKIR (TR) | 2014-03-20 | — | — | WO | claimed |
| WO-2014041513-A1 | A MATERIAL USED FOR PHOSPHOPEPTIDE ENRICHMENT AND A PRODUCTION METHOD THEREOF | SALIH BEKIR (TR) | 2014-03-20 | — | — | WO | disclosed |